NO20030700L - Mikronisert torsemid - Google Patents

Mikronisert torsemid

Info

Publication number
NO20030700L
NO20030700L NO20030700A NO20030700A NO20030700L NO 20030700 L NO20030700 L NO 20030700L NO 20030700 A NO20030700 A NO 20030700A NO 20030700 A NO20030700 A NO 20030700A NO 20030700 L NO20030700 L NO 20030700L
Authority
NO
Norway
Prior art keywords
torsemide
micronized
micronized torsemide
Prior art date
Application number
NO20030700A
Other languages
English (en)
Norwegian (no)
Other versions
NO20030700D0 (no
Inventor
Marco Kordova
Anchel Schwartz
Ben-Zion Dolitzky
Judith Aronhime
David Leonov
Shlomo Zavurov
Szabolcs Salyi
Erzsebet Meszaros-Sos
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharma filed Critical Teva Pharma
Publication of NO20030700D0 publication Critical patent/NO20030700D0/no
Publication of NO20030700L publication Critical patent/NO20030700L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Materials For Medical Uses (AREA)
NO20030700A 2000-08-14 2003-02-13 Mikronisert torsemid NO20030700L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22536500P 2000-08-14 2000-08-14
PCT/US2001/025415 WO2002013823A1 (en) 2000-08-14 2001-08-14 Micronized torsemide

Publications (2)

Publication Number Publication Date
NO20030700D0 NO20030700D0 (no) 2003-02-13
NO20030700L true NO20030700L (no) 2003-02-13

Family

ID=22844578

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030700A NO20030700L (no) 2000-08-14 2003-02-13 Mikronisert torsemid

Country Status (11)

Country Link
US (1) US20020120147A1 (is)
EP (1) EP1318809A1 (is)
JP (1) JP2004511439A (is)
KR (1) KR20030051618A (is)
AU (1) AU2001286468A1 (is)
CA (1) CA2419081A1 (is)
IL (1) IL154457A0 (is)
IS (1) IS6712A (is)
NO (1) NO20030700L (is)
PL (1) PL366219A1 (is)
WO (1) WO2002013823A1 (is)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200522943A (en) * 2003-12-11 2005-07-16 Kyowa Hakko Kogyo Kk Fine crystallites and a pharmaceutical composition comprising them
WO2006090350A1 (en) * 2005-02-28 2006-08-31 Ranbaxy Laboratories Limited A method for sieving pharmaceutical substances
EP2156837B1 (en) * 2007-05-21 2017-04-26 Toray Industries, Inc. Crystalline micropowder particles

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2642486B2 (ja) * 1989-08-04 1997-08-20 田辺製薬株式会社 難溶性薬物の超微粒子化法
DE4323636A1 (de) * 1993-07-15 1995-01-19 Hoechst Ag Arzneistoffzubereitungen aus umhüllten, schwerstwasserlöslichen Arzneistoffen für Inhalationsarzneiformen und Verfahren zu ihrer Herstellung

Also Published As

Publication number Publication date
KR20030051618A (ko) 2003-06-25
WO2002013823A1 (en) 2002-02-21
PL366219A1 (en) 2005-01-24
EP1318809A1 (en) 2003-06-18
IS6712A (is) 2003-02-11
CA2419081A1 (en) 2002-02-21
US20020120147A1 (en) 2002-08-29
AU2001286468A1 (en) 2002-02-25
IL154457A0 (en) 2003-09-17
JP2004511439A (ja) 2004-04-15
NO20030700D0 (no) 2003-02-13

Similar Documents

Publication Publication Date Title
EE200200387A (et) Fulvestrandi formulatsioonid
DK1292604T3 (da) 2-Aminocarbonyl-9H-purinderivater
FI20105657A (fi) Farmaseuttisia koostumuksia
AR028204A1 (es) Composiciones farmaceuticas electrohiladas
ITMI20010748A0 (it) Composizioni farmaceutiche
ATE288437T1 (de) Tetrahydro-heterocycloazepinyl-pyrimidin-deriva e
DE50114386D1 (de) Ng
ATE298332T1 (de) Decahydro-isochinolinderivate
DK1280809T3 (da) Antitumorecteinascidinderivater
NO20030276D0 (no) Fremgangsmåte
NO20026123L (no) Farmasöytiske sammensetninger
AR028336A1 (es) 4-hidroxi-tetrahidropiridonas fenilsubstituidas
NO20031095D0 (no) Farmasöytiske sammensetninger
DK1322593T3 (da) O-substituerede-6-methyl-tramadol-derivater
AR028061A1 (es) 2-enamino-cetonitrilos fenil-substituidos
ATE268116T1 (de) Mesotrion-formulierungen
AR027931A1 (es) Antitranspirantes
NO20022983D0 (no) Aminometyl-fenyl-cykloheksanonderivater
AR027982A1 (es) Aril- y heteroarilsulfonatos
NO20030700L (no) Mikronisert torsemid
ATE374776T1 (de) Pyrrolotriazolopyrimidinonderivate
NO20024393D0 (no) 2-fenylpyran-4-on-derivater
AT500246B8 (de) Chokerring
FR2817889B1 (fr) Coffrage
EE200200689A (et) Ravimkoostised